کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3978746 1601064 2013 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Plateformes de biologie moléculaire en oncologie thoracique : quelles recherches, pour qui ?
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی تومور شناسی
پیش نمایش صفحه اول مقاله
Plateformes de biologie moléculaire en oncologie thoracique : quelles recherches, pour qui ?
چکیده انگلیسی
Management of NSCLC patients is more and more individualized especially on the base of bioguided treatments. In order to guarantee an access for all the patients too this type of strategy, the French NCI supports since 2006 a nationwide network of 28 regional genetics center. The financial support is based on public funds. The French NCI recommends today the assessment of seven biomarkers for all stage IV non squamous NSCLC patients. Due to financial and technical reasons, this recommendation must be followed. However, the molecular profiling of lung cancer patients would ideally be extended across all stages and all histological types of the disease in order to improve our knowledge in this field and provides the patient with an opportunity to access a bioguided treatment as frequently as possible.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Bulletin du Cancer - Volume 100, Issues 7–8, July–August 2013, Pages 737-741
نویسندگان
, , , , , , , ,